Mayo Clinic Laboratories, a global leader in advanced laboratory testing, and KYAN Technologies, a leader in functional precision medicine for oncology, today announced a collaboration to validate and provide the KYAN test, Optim.AI™, across the United States. This collaboration aims to support clinicians with additional testing insights for cancer treatment.
Learn more here.
/Public Release, Courtesy: Mayo Clinic. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
